NCT00526279View on ClinicalTrials.gov

COmpliance and Efficacy in Mono and Combination Tablet Study ATacand/Atacand Plus

CompletedOBSERVATIONAL
Enrollment

9,000

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Hypertension
Trial Locations (3)

Unknown

Research Site, Seoul

Research Site, Seoul

Research Site, Seoul

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY